Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy Bandala

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
American Journal of Cancer Research|May 18, 2016
Association of CYP8A1 (Prostacyclin I2 synthase) polymorphism rs5602 with breast cancer in Mexican womanEduardo Beltran-Sarmiento, Esaú Floriano-Sánchez, Cindy Bandala, et al.
Expert Opinion on Therapeutic Patents|May 14, 2020
Bispecific anti-PD-1/LAG-3 antibodies for treatment of advanced or metastatic solid tumors: a patent evaluation of US2018326054Jorge Cebada, Amira Flores, Cindy Bandala, et al.
Expert Opinion on Therapeutic Patents|February 29, 2020
Colon carcinoma treatment using bispecific anti-GITR/CTLA-4 antibodies: a patent evaluation of WO2018091739Lourdes Millán-Pérez Peña, Perez-Santos Martin, Irma Herrera-Camacho, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2013
Effect of botulinum toxin A on proliferation and apoptosis in the T47D breast cancer cell lineCindy Bandala, Jose Luis Martin Perez-Santos, Eleazar Lara-Padilla, et al.
International Journal of Molecular Sciences|June 26, 2026
Molecular Mechanisms Underlying Recurrence in Triple-Positive Breast Cancer (ER+/PR+/HER2+) and Potential Repurposing of Multi-Target InhibitorsCindy Bandala, José Anselmo López-Méndez, María R J Díaz-Rivera, et al.
Expert Opinion on Therapeutic Patents|June 27, 2019
Cancer immunotherapy using anti-TIM3/PD-1 bispecific antibody: a patent evaluation of EP3356411A1Irma Herrera-Camacho, Maricruz Anaya-Ruiz, Martin Perez-Santos, et al.
Expert Opinion on Therapeutic Patents|October 26, 2024
Trispecific anti-CD3/BCMA/CD38 antibodies for multiple myeloma: a patent evaluation of US20240132615Cindy Bandala, Donaciano Flores-Robles, Pavel Sierra-Martínez, et al.
Expert Opinion on Therapeutic Patents|July 11, 2019
LAG-3 antagonists by cancer treatment: a patent reviewMartin Perez-Santos, Maricruz Anaya-Ruiz, Jorge Cebada, et al.
Journal of Clinical Medicine|June 27, 2024
Efficacy between Conventional Laparoscopy and Robotic Surgery in Mexican Patients with Endometriosis: A Comparative StudyCindy Bandala, Juan Pablo Cifuentes-Chacón, Alfredo Cortes-Vázquez, et al.
Neurology India|November 10, 2022
Neuropathic Pain in Parkinson's DiseaseJose Luis Cortes-Altamirano, Samuel Reyes-Long, Cindy Bandala, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
American Journal of Cancer Research|May 18, 2016
Association of CYP8A1 (Prostacyclin I2 synthase) polymorphism rs5602 with breast cancer in Mexican womanEduardo Beltran-Sarmiento, Esaú Floriano-Sánchez, Cindy Bandala, et al.
Expert Opinion on Therapeutic Patents|May 14, 2020
Bispecific anti-PD-1/LAG-3 antibodies for treatment of advanced or metastatic solid tumors: a patent evaluation of US2018326054Jorge Cebada, Amira Flores, Cindy Bandala, et al.
Expert Opinion on Therapeutic Patents|February 29, 2020
Colon carcinoma treatment using bispecific anti-GITR/CTLA-4 antibodies: a patent evaluation of WO2018091739Lourdes Millán-Pérez Peña, Perez-Santos Martin, Irma Herrera-Camacho, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 30, 2013
Effect of botulinum toxin A on proliferation and apoptosis in the T47D breast cancer cell lineCindy Bandala, Jose Luis Martin Perez-Santos, Eleazar Lara-Padilla, et al.
International Journal of Molecular Sciences|June 26, 2026
Molecular Mechanisms Underlying Recurrence in Triple-Positive Breast Cancer (ER+/PR+/HER2+) and Potential Repurposing of Multi-Target InhibitorsCindy Bandala, José Anselmo López-Méndez, María R J Díaz-Rivera, et al.
Expert Opinion on Therapeutic Patents|June 27, 2019
Cancer immunotherapy using anti-TIM3/PD-1 bispecific antibody: a patent evaluation of EP3356411A1Irma Herrera-Camacho, Maricruz Anaya-Ruiz, Martin Perez-Santos, et al.
Expert Opinion on Therapeutic Patents|October 26, 2024
Trispecific anti-CD3/BCMA/CD38 antibodies for multiple myeloma: a patent evaluation of US20240132615Cindy Bandala, Donaciano Flores-Robles, Pavel Sierra-Martínez, et al.
Expert Opinion on Therapeutic Patents|July 11, 2019
LAG-3 antagonists by cancer treatment: a patent reviewMartin Perez-Santos, Maricruz Anaya-Ruiz, Jorge Cebada, et al.
Journal of Clinical Medicine|June 27, 2024
Efficacy between Conventional Laparoscopy and Robotic Surgery in Mexican Patients with Endometriosis: A Comparative StudyCindy Bandala, Juan Pablo Cifuentes-Chacón, Alfredo Cortes-Vázquez, et al.
Neurology India|November 10, 2022
Neuropathic Pain in Parkinson's DiseaseJose Luis Cortes-Altamirano, Samuel Reyes-Long, Cindy Bandala, et al.
Pageof 8